Tue.Jul 30, 2024

article thumbnail

CVS PBM to Pay $45 Million in Rebates to State of Illinois

Drug Topics

CVS Caremark and the State of Illinois settled a lawsuit due to the company’s failure to pay contracted rebates.

266
266
article thumbnail

CDC will offer seasonal flu shots to farmworkers to lower bird flu risk

STAT

The Centers for Disease Control and Prevention announced Tuesday that it is funding a $5 million program to vaccinate livestock industry workers against seasonal flu in a bid to reduce the pandemic risk posed by the ongoing H5N1 bird flu outbreak in cattle. The voluntary program, which will be administered by state and local public health workers, is aimed at getting seasonal flu shots into as many people as possible who are working in proximity to animals — poultry, cows, or other livest

Vaccines 144
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharmacy Focus - Oncology Edition: The Link Between Gut Health and Colon Cancer, Exploring the Wellness Innovation Network

Pharmacy Times

Jennifer Dunphy, DrPH, MBA, MPH and Nelly Awkar-Lazo, MD, discuss the rise in young-onset cancer, the gut-colon cancer link, and the importance of healthy lifestyle choices for cancer prevention.

132
132
article thumbnail

STAT+: Dental AI startup raises $30 million, including from Mark Zuckerberg’s dad

STAT

As the AI race in dentistry grows more heated, a startup called Perceptive is aiming to automate each stage of a dental visit, from imaging to treatment recommendations to the actual surgical procedure. The Boston startup, which recently came out of stealth mode, announced on Tuesday that it has received $30 million in funding to work on a dental system that includes a hand-held imaging machine, an AI algorithm to help diagnose and suggest treatment, and a surgical robot to complete the procedur

FDA 143
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Nearly half of beneficiaries don't know the difference between Medicare and MA: survey

Fierce Healthcare

The U.S. healthcare system remains complex and inaccessible, leaving many seniors feeling uninformed, according to a new survey from digital health company DUOS. | Seniors are growing more comfortable with technology, but many still don't understand key differences between major health programs.

131
131
article thumbnail

STAT+: Older GLP-1 drug may help protect brains of Alzheimer’s patients, early study suggests

STAT

A new study suggests that an older GLP-1 drug may help protect the brains of people with early Alzheimer’s disease, supporting the case for further research on the class of medications — originally developed for obesity and diabetes — in neurological diseases. The Phase 2 randomized trial, led by researchers at Imperial College London, tested Novo Nordisk’s liraglutide, the predecessor to Ozempic and Wegovy, in patients with early Alzheimer’s disease over one y

143
143

More Trending

article thumbnail

STAT+: Wells Fargo faces class action lawsuit over workers’ high drug costs

STAT

Former employees sued Wells Fargo on Tuesday, alleging the banking giant violated federal law by not diligently monitoring how much it was paying for their prescription drugs, which led to massive overcharges. The class action lawsuit is the second of its kind filed in federal court, further heightening the legal risks for employers that don’t scrutinize how they purchase health and drug benefits for their workers.

Insurance 144
article thumbnail

Ochsner Health going all-in on ambient AI, taps DeepScribe to deploy tech for 4,700 physicians

Fierce Healthcare

Ochsner Health is going all-in on ambient AI voice technology for its thousands of doctors and has inked an enterprise agreement to roll out DeepScribe's technology across its health system. | Ochsner Health inked an enterprise-wide agreement with DeepScribe to roll out its AI medical scribe across its 46-hospital system for 4,700 providers.

Hospitals 130
article thumbnail

There’s more data for trans people with HIV than any other disease — but it’s still flawed

STAT

Transgender people are at higher-than-average risk of contracting HIV. And yet, when epidemiologist Diana Tordoff set out to analyze how transmission of the virus might change in the U.S. over the next 10 years with increased testing and preventative PrEP medication, she found there wasn’t enough existing data on trans and nonbinary people to answer the question for those populations.

138
138
article thumbnail

How the feds should handle rampant insurer upcoding

Fierce Healthcare

Enforcement and physician education are two keys to limiting health plan upcoding, a costly scheme that exploits the Medicare system, health policy experts told Fierce Healthcare. | Health plan upcoding threatens the Medicare system. Here's how policy experts believe the federal government should pursue abuse.

Insurance 122
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

STAT+: Health care’s ‘Pepsi challenge’: Doctors’ offices are testing AI tools in head-to-head pilots

STAT

The “Pepsi challenge” of health care, as one health system executive put it, is on. In the race to test generative AI in medicine, ambient scribes — which listen in to the audio of a visit and turn it into a structured clinical note for the electronic health record — are leading the pack. And to find the right scribe at the right price, health systems are pitting them against each other.

article thumbnail

Ready-to-Use Phosphorus Solution From Amneal Pharmaceuticals Wins FDA Approval

Drug Topics

The new FDA-approved presentation will be the company’s third 505(b)(2) injectable added in 2024, expected to launch in the third quarter.

FDA 112
article thumbnail

STAT+: NIH loses suit over censoring social media comments made by animal rights advocates

STAT

In a boost for animal rights advocates, a U.S. appeals court ruled that a National Institutes of Health policy for monitoring comments posted to its online forums violated the First Amendment because the agency made a point of removing remarks about animal testing. At issue was an effort by the NIH to exclude “off-topic” discussions about its work.

138
138
article thumbnail

Five Fast Facts About IVIG

Pharmacy Times

By functioning as an antibody replacement therapy, IVIG can be used to manage a wide range of inflammatory and autoimmune disorders.

132
132
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Opinion: How artificial intelligence can bolster Europe’s competitive edge in biopharma

STAT

In a year marked by European Parliament elections and setting of the European Union’s priorities for the next five years, it’s time for the EU to make innovation in health and biopharmaceuticals a strategic priority for the region’s resilience and security. Europe is currently facing a competitiveness crisis. EU productivity has declined 1.2% in the fourth quarter of 2023 compared to the previous year, while U.S. productivity rose 2.6%.

134
134
article thumbnail

A symbiotic relationship for optimal AI-powered healthcare

pharmaphorum

Discover how OPEN Health and fusion's AI technology partnership is creating a symbiotic relationship that is revolutionising healthcare. Explore the benefits of this for optimal patient care.

article thumbnail

Substance use stayed at high levels in 2023, while vaping increased and smoking fell

STAT

Rates of mental illness and substance use remained largely stable in 2023, according to federal data, underscoring the severity of the long-running U.S. mental health crisis and worst-in-the-world rates of illicit drug use. And while overall rates of nicotine use also remained roughly even, the way people consumed it shifted slightly. Overall, slightly more Americans vaped nicotine, while slightly fewer smoked cigarettes.

132
132
article thumbnail

CMS, HHS can use existing federal authority to regulate AI safety in hospitals: JAMA

Fierce Healthcare

As artificial intelligence rapidly makes inroads in healthcare, federal agencies already have the authority to regulator AI at the hospital bedside, according to some healthcare researche | An article published in JAMA Health Forum argues that through the conditions of participation in Medicare and Medicaid, CMS has the authority to oversee how hospitals are implementing AI into patient care.

Hospitals 129
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

STAT+: Wells Fargo faces class action lawsuit over workers’ high drug costs

STAT

Former employees sued Wells Fargo on Tuesday, alleging the banking giant violated federal law by not diligently monitoring how much it was paying for their prescription drugs, which led to massive overcharges. The class action lawsuit is the second of its kind filed in federal court, further heightening the legal risks for employers that don’t scrutinize how they purchase health and drug benefits for their workers.

Insurance 131
article thumbnail

FDA Extends Palforzia Approval to Children 1 to 3 Years Old With Peanut Allergy

Pharmacy Times

The approval marks the first oral immunotherapy treatment to mitigate allergic reactions, including anaphylaxis.

FDA 139
article thumbnail

STAT+: Eisai, Biogen make case for long-term use of Alzheimer’s drug Leqembi with new data

STAT

Patients with early Alzheimer’s disease treated with a medication developed by Eisai and Biogen for up to three years experienced less cognitive decline than what’s expected of untreated patients based on historical data, according to new study results reported Tuesday. The manufacturers said the data support long-term, continuous use of the drug.

123
123
article thumbnail

Eco HPLC-based method shows promise for Z-alkene synthesis

European Pharmaceutical Review

Japanese researchers have developed a new method for photoisomerisation of E -cinnamamides to Z -cinnamamides. The approach uses a recycling photoreactor coupled with a high-performance liquid chromatography (HPLC) system. As organic compounds, many Z -alkenes “cannot be prepared through conventional methods involving thermodynamic methods”. On the other hand, “photoisomerisation can offer good yields”, they noted.

article thumbnail

STAT+: Merck shares fall as sales of HPV vaccine drop in China

STAT

Shares of Merck fell 9% Tuesday after the company reported that in the second quarter, it saw a decrease in shipments of its HPV vaccine Gardasil in China, a significant market for the drug. The company brought in $2.48 billion in sales of Gardasil in the second quarter, slightly lower than estimates of $2.5 billion made by analysts polled by Visible Alpha.

Vaccines 125
article thumbnail

Tezepelumab Reduces Exacerbations in Patients With Severe, Uncontrolled Asthma

Pharmacy Times

Compared with placebo, tezepelumab reduced the annual asthma exacerbation rate in multiple subpopulations and asthma-related comorbidities.

123
123
article thumbnail

5 cybersecurity guidelines for remote monitoring in clinical trials

pharmaphorum

Implementing strong cybersecurity guidelines for remote monitoring in clinical trials is crucial to protect sensitive data. Learn these top 5 guidelines to secure your remote monitoring plan effectively.

111
111
article thumbnail

Pfizer tacks on $1B to 2024 revenue outlook amid cost-cutting drive

Fierce Pharma

For more than a year after Pfizer’s COVID product sales peaked at the end of 2022, the company’s quarterly revenues showed year-over-year declines. | For the first time since its sales peaked during the pandemic, Pfizer registered year-over-year revenue growth during the second quarter of 2024. And while the busy has been busy trimming operating expenses, it did add $1 billion to its total revenue projection for the year.

113
113
article thumbnail

Community Pharmacy Managers, Owners Must Address Workplace Violence

Pharmacy Times

Although important for patient health care, pharmacies’ convenient locations leave staff prone to workplace violence.

article thumbnail

Approaching the regulatory world with passion: CERs and EU MDR processes

pharmaphorum

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Ethan Drower, co-founder and CEO of Cite Medical Solutions, a company providing full Clinical Evaluation Report (CER) services and industry literature review for European Union Medical Device Regulation (or EU MDR) processes.

108
108
article thumbnail

Avutometinib With Defactinib Granted FDA Orphan Drug Designation to Treat Pancreatic Cancer

Pharmacy Times

The designation is based off positive results from the RAMP 205 trial presented at the ASCO Annual Meeting.

FDA 138
article thumbnail

U.S. indicts North Korean hacker for leading ransomware attacks against hospitals

Fierce Healthcare

A federal grand jury indicted a North Korean national for allegedly leading ransomware attacks in 2022 against U.S. hospitals. | A federal grand jury indicted a North Korean national for allegedly leading ransomware attacks against U.S. hospitals. The government is offering a reward of up to $10 million for information on the hacker and other cybercriminals targeting critical infrastructure.

Hospitals 112
article thumbnail

Cinnamon May Reduce Risk of Cardiovascular Disease in Patients with PCOS

Pharmacy Times

Polycystic ovary syndrome (PCOS) is closely associated with an increased risk of cardiovascular disease.

139
139
article thumbnail

Testing GLP-1s in Alzheimer’s, and is Medicare a good negotiator?

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning. If anything will motivate me to get through this week, it’s knowing that Simone Biles went on to nail the most difficult vault even while experiencing calf problems. That and also everyone’s new obsession over pommel horse king Stephen Nedoroscik.

107
107
article thumbnail

BioNTech cancer vaccine hits the spot in melanoma

pharmaphorum

mRNA specialist BioNTech has chalked up an important win in its cancer pipeline, showing efficacy with its BNT111 vaccine candidate in a phase 2 trial in advanced melanoma.The study is looking at the combination of BNT111 with Regeneron's PD-1 inhibitor Libtayo (cemiplimab) in 184 patients with advanced melanoma who have relapsed after or not responded to treatment with a PD-1/PD-L1 inhibitor, or the two therapies given alone.

Vaccines 100